Cargando…

Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation

BACKGROUND: Galectin-3 is a marker of myocardial inflammation and fibrosis shown to correlate with morbidity and mortality in heart failure (HF). We examined the utility of galectin-3 as a marker of the severity of HF, the response of galectin-3 levels to ventricular assist device (LVAD) implantatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coromilas, Ellie, Que-Xu, Em-Claire, Moore, D’Vesharronne, Kato, Tomoko S., Wu, Christina, Ji, Ruiping, Givens, Raymond, Jorde, Ulrich P., Takayama, Hiroo, Naka, Yoshifumi, George, Isaac, Mancini, Donna, Schulze, P. Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906704/ https://www.ncbi.nlm.nih.gov/pubmed/27301475 http://dx.doi.org/10.1186/s12872-016-0298-z

Ejemplares similares

Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure
por: Khawaja, Tuba, et al.
Publicado: (2014)

Erratum to: Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure
por: Khawaja, Tuba, et al.
Publicado: (2014)

Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation
por: Schulze‐Späte, Ulrike, et al.
Publicado: (2017)

Malignant ventricular arrhythmias in patients with severe acute respiratory distress syndrome due to COVID-19 without significant structural heart disease
por: Abrams, Mark P., et al.
Publicado: (2020)

Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
por: Hayashi, Hideyuki, et al.
Publicado: (2021)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Prognostic Value of Galectin-3 in Patients with Heart Failure
por: Bošnjak, Ivica, et al.
Publicado: (2015)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure
por: Inoue, Keiko, et al.
Publicado: (2022)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

Galectin-3 in Heart Failure: More Answers or More Questions?
por: Ahmad, Tariq, et al.
Publicado: (2012)

Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites
por: McEvoy, John W., et al.
Publicado: (2016)

Galectin-3: a novel biomarker for the prognosis of heart failure
por: AMIN, HILMAN ZULKIFLI, et al.
Publicado: (2017)

Obesity, Galectin‐3, and Incident Heart Failure: The ARIC Study
por: Florido, Roberta, et al.
Publicado: (2022)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter?
por: Fabiani, Iacopo, et al.
Publicado: (2023)

The prognostic role of galectin-3 and endothelial function in patients with heart failure
por: Tsigkou, Vasiliki, et al.
Publicado: (2023)

Galectin-4 is associated with diabetes and obesity in a heart failure population
por: Dieden, Anna, et al.
Publicado: (2023)

Value of Galectin-3 assay in children with heart failure secondary to congenital heart diseases: a prospective study
por: Saleh, Nagwan, et al.
Publicado: (2020)

Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve
por: Holmager, Pernille, et al.
Publicado: (2017)

Estimating the causal effect of the Medicaid expansion on heart transplant volume with a differences-in-differences model
por: Palaniappan, Ashwin, et al.
Publicado: (2022)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Studies on the role of goat heart galectin-1 as an erythrocyte membrane perturbing agent
por: Ashraf, Ghulam Md, et al.
Publicado: (2014)

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure
por: van Vark, Laura C., et al.
Publicado: (2017)

Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
por: Caravaca Perez, Pedro, et al.
Publicado: (2022)

Levels of Galectin-3 in Chronic Heart Failure: A Case-Control Study
por: Khadeja Bi, Altaff, et al.
Publicado: (2022)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure
por: Stoltze Gaborit, Freja, et al.
Publicado: (2016)

Relationship of Plasma Galectin-3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
por: Gopal, Deepa M., et al.
Publicado: (2012)

Loss of Left Ventricular Vortex Ring in Left Ventricular Assist Device-Induced Right Ventricular Failure
por: Akiyama, Koichi, et al.
Publicado: (2023)

Model of unidirectional block formation leading to reentrant ventricular tachycardia in the infarct border zone of postinfarction canine hearts
por: Ciaccio, Edward J., et al.
Publicado: (2015)

Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation
por: Jennings, Douglas L., et al.
Publicado: (2020)

Reprint of 'Model of unidirectional block formation leading to reentrant ventricular tachycardia in the infarct border zone of postinfarction canine hearts'
por: Ciaccio, Edward J., et al.
Publicado: (2015)

Galectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients
por: Iacoviello, Massimo, et al.
Publicado: (2015)

Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure
por: Komici, Klara, et al.
Publicado: (2020)

Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis
por: Cheng, Zhendong, et al.
Publicado: (2022)

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023)

The Role of Galectin-3 in Predicting Congenital Heart Disease Outcome: A Review of the Literature
por: Făgărășan, Amalia, et al.
Publicado: (2023)

Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
por: Lima, Tânia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hc4n874960ihsr3ldvltru88i6